+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Marine Pharmaceuticals Market 2021-2025- Product Image

Global Marine Pharmaceuticals Market 2021-2025

  • ID: 5300882
  • Report
  • February 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • BeyondSpring Inc.
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Jazz Pharmaceuticals Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Marine Pharmaceuticals Market 2021-2025

The publisher has been monitoring the marine pharmaceuticals market and it is poised to grow by $1.43 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. The report on marine pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the licensing agreements, special drug designations, and vast availability of raw materials. In addition, licensing agreements is anticipated to boost the growth of the market as well.

The marine pharmaceuticals market analysis includes product segment and geographical landscapes.

The marine pharmaceuticals market is segmented as below:

By Product
  • Oncology
  • Cardiovascular
  • Anti-infectives
  • Others
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the marine peptides as anti-infectives as one of the prime reasons driving the marine pharmaceuticals market growth during the next few years. Also, research for anti-inflammatory compounds from marine sources and increasing clinical trials will lead to sizable demand in the market.

Thereport on marine pharmaceuticals market covers the following areas:
  • Marine pharmaceuticals market sizing
  • Marine pharmaceuticals market forecast
  • Marine pharmaceuticals market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading marine pharmaceuticals market vendors that include BeyondSpring Inc., Bristol-Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Pfizer Inc., PharmaMar SA, F. Hoffmann-La Roche Ltd., Seagen Inc., and TerSera Therapeutics LLC. Also, the marine pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BeyondSpring Inc.
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Jazz Pharmaceuticals Plc
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Oncology - Market size and forecast 2020-2025
  • Cardiovascular - Market size and forecast 2020-2025
  • Anti-infectives - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Product
Market Segmentation by Source
  • Invertebrate
  • Vertebrate
  • Others
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • BeyondSpring Inc.
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
  • Jazz Pharmaceuticals Plc
  • Pfizer Inc.
  • PharmaMar SA
  • F. Hoffmann-La Roche Ltd.
  • Seagen Inc.
  • TerSera Therapeutics LLC
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Oncology - Market size and forecast 2020-2025 ($ million)
  • Oncology - Year-over-year growth 2020-2025 (%)
  • Cardiovascular - Market size and forecast 2020-2025 ($ million)
  • Cardiovascular - Year-over-year growth 2020-2025 (%)
  • Anti-infectives - Market size and forecast 2020-2025 ($ million)
  • Anti-infectives - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ million)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • BeyondSpring Inc. - Overview
  • BeyondSpring Inc. - Product and service
  • BeyondSpring Inc. - Key offerings
  • BeyondSpring Inc. - Key customers
  • BeyondSpring Inc. - Segment focus
  • Bristol-Myers Squibb Co. - Overview
  • Bristol-Myers Squibb Co. - Product and service
  • Bristol-Myers Squibb Co. - Key offerings
  • Bristol-Myers Squibb Co. - Key customers
  • Bristol-Myers Squibb Co. - Segment focus
  • Eisai Co. Ltd. - Overview
  • Eisai Co. Ltd. - Business segments
  • Eisai Co. Ltd. - Key offerings
  • Eisai Co. Ltd. - Key customers
  • Eisai Co. Ltd. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Jazz Pharmaceuticals Plc - Overview
  • Jazz Pharmaceuticals Plc - Business segments
  • Jazz Pharmaceuticals Plc - Key offerings
  • Jazz Pharmaceuticals Plc - Key customers
  • Jazz Pharmaceuticals Plc - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • PharmaMar SA - Overview
  • PharmaMar SA - Business segments
  • PharmaMar SA - Key offerings
  • PharmaMar SA - Key customers
  • PharmaMar SA - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Seagen Inc. - Overview
  • Seagen Inc. - Business segments
  • Seagen Inc. - Key offerings
  • Seagen Inc. - Key customers
  • Seagen Inc. - Segment focus
  • TerSera Therapeutics LLC - Overview
  • TerSera Therapeutics LLC - Product and service
  • TerSera Therapeutics LLC - Key offerings
  • TerSera Therapeutics LLC - Key customers
  • TerSera Therapeutics LLC - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BeyondSpring Inc.
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Jazz Pharmaceuticals Plc
The publisher recognizes the following companies as the key players in the global marine pharmaceuticals market: BeyondSpring Inc., Bristol-Myers Squibb Co., Eisai Co. Ltd., GlaxoSmithKline Plc, Jazz Pharmaceuticals Plc, Pfizer Inc., PharmaMar SA, F. Hoffmann-La Roche Ltd., Seagen Inc., and TerSera Therapeutics LLC.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is marine peptides as anti-infectives.'

According to the report, one of the major drivers for this market is the licensing agreements.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • BeyondSpring Inc.
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • GlaxoSmithKline Plc
  • Jazz Pharmaceuticals Plc
  • Pfizer Inc.
  • PharmaMar SA
  • F. Hoffmann-La Roche Ltd.
  • Seagen Inc.
  • TerSera Therapeutics LLC
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll